/news/tags/athersys Athersys en-US Copyright Fri, 01 May 2020 16:03:51 GMT /news/health-science/2020-05-01/uh-athersys-testing-possible-therapy-for-deadly-covid-19-complication Updated on May 1, 2020 at 12pm Athersys, a biotechnology company in Cleveland, has been developing a possible therapy for serious medical conditions such as acute respiratory distress syndrome (ARDS) – one of the more concerning complications caused by COVID-19. The company announced in a press release on Friday May 1, 2020, that University Hospitals is starting a clinical trial testing the effectiveness of this treatment on patients with COVID-19 induced ARDS. Fri, 01 May 2020 16:03:51 GMT /news/health-science/2020-05-01/uh-athersys-testing-possible-therapy-for-deadly-covid-19-complication